YTHDF2 and nonpapillary renal cell carcinoma: It was reported that YTHDF2 was overexpressed in both bladder cancer and prostate cancer  (PCa) [65–67] and was remarkably downregulated in clear cell renal cell carcinoma (ccRCC) [68].